Sarah Gheuens, insider filing for AGIO
Sarah Gheuens, reporting
Every EDGAR filing for AGIOS PHARMACEUTICALS, INC. (AGIO), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 2 · 10-Q expected ~Nov 2 (deadline Nov 9)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Sarah Gheuens, insider filing for AGIO
Sarah Gheuens, reporting
Sarah Gheuens, planned sale of AGIO shares
Sarah Gheuens, reporting
Ownership stake disclosure by FARALLON CAPITAL MANAGEMENT, L.L.C. (amended)
FARALLON CAPITAL MANAGEMENT, L.L.C., filed by
Jay T. Backstrom, insider filing for AGIO
Jay T. Backstrom, reporting
Ownership stake disclosure by D. E. SHAW & CO, L.P.
D. E. SHAW & CO, L.P., filed by
Sarah Gheuens, insider filing for AGIO
Sarah Gheuens, reporting
Sarah Gheuens, planned sale of AGIO shares
Sarah Gheuens, reporting
Rahul D. Ballal, insider filing for AGIO
Rahul D. Ballal, reporting
Adams Catherine Owen, insider filing for AGIO
Adams Catherine Owen, reporting
Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)
ARMISTICE CAPITAL, LLC, filed by
Ownership stake disclosure by Lynx1 Capital Management LP
Lynx1 Capital Management LP, filed by
Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
James William Burns, insider filing for AGIO
James William Burns, reporting
Brian Goff, planned sale of AGIO shares
Brian Goff, reporting
Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
Krishnan Viswanadhan, insider filing for AGIO
Krishnan Viswanadhan, reporting